APO2 ligand/trail formulations

Details for Australian Patent Application No. 2010201713 (hide)

Owner Genentech, Inc.

Inventors Flores, Heather; Lin, Tanya P.; Pai, Roger; Matthews, Timothy C.; Shahrokh, Zahra

Agent Griffith Hack

Pub. Number AU-B-2010201713

Parent 2007200478

Filing date 29 April 2010

Wipo publication date 20 May 2010

Acceptance publication date 10 May 2012

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61J 1/06 (2006.01) Containers specially adapted for medical or pharmaceutical purposes - Ampoules or cartridges

A61J 1/14 (2006.01) Containers specially adapted for medical or pharmaceutical purposes - Details

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/198 (2006.01)

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 33/30 (2006.01) Medicinal preparations containing inorganic active ingredients - Zinc

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61M 11/06 (2006.01) Sprayers - of the injector type

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

13 May 2010 Complete Application Filed

20 May 2010 Application Open to Public Inspection

  Published as AU-B-2010201713

10 May 2012 Application Accepted

  Published as AU-B-2010201713

6 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201714-Method and device for implementing ultra far coverage

2010201712-2'-substituted oligomeric compounds and compositions for use in gene modulations